Impact of Pre-surgical Nasal Bacterial Reduction on Postoperative Surgical Site Infections / Standard Care Change

3M Company

Status: Terminated

Conditions: Surgical Site Infection

Treatments: Drug: 3M Skin and Nasal Antiseptic

Study type: Observational

Funder types: Other; Industry

Identifiers

NCT01148030

11319

Details and patient eligibility

About

Patients presenting in the Emergency Department or admitted to the hospital with displaced hip fractures who require hemiarthroplasty or open reduction internal fixation or with spinal instability/fractures in need of urgent surgical intervention will receive treatment to reduce the number of microorganisms in their nose prior to surgery. After surgery, the subjects will be observed for any surgical site infections.

Full description

Infection rate study.

Enrollment: 333 patients

Sex: All

Ages: 2+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Patients presenting in the Emergency Department or admitted to the hospital with displaced hip fractures who require hemiarthroplasty or open reduction internal fixation or with spinal instability/fractures in need of urgent surgical intervention will be enrolled in the study.

Trial design

333 participants in 1 patient group

Single

Description:

3M Skin and Nasal Antiseptic

Treatment:

Drug: 3M Skin and Nasal Antiseptic